Valuation IDEXX Laboratories, Inc.
Stocks
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
15:38:50 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 675.10 USD | +0.51% |
|
+20.34% | -0.16% |
Company Valuation: IDEXX Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 55,833 | 33,786 | 46,098 | 33,854 | 54,022 | 52,913 | - | - |
| Change | - | -39.49% | 36.44% | -26.56% | 59.57% | -2.05% | - | - |
| Enterprise Value (EV) 1 | 56,612 | 35,022 | 46,592 | 34,434 | 54,690 | 53,014 | 52,822 | 52,249 |
| Change | - | -38.14% | 33.04% | -26.09% | 58.83% | -3.06% | -0.36% | -1.09% |
| P/E | 76.6x | 50.8x | 55.2x | 38.7x | 51.7x | 45.3x | 40.3x | 35.4x |
| PBR | 82.6x | 55.6x | 31x | 21.6x | 34.1x | 26.9x | 19.8x | 14.4x |
| PEG | - | -7.66x | 2.2x | 6.38x | 2.3x | 3.4x | 3.3x | 2.5x |
| Capitalization / Revenue | 17.4x | 10x | 12.6x | 8.69x | 12.6x | 11.1x | 10.2x | 9.37x |
| EV / Revenue | 17.6x | 10.4x | 12.7x | 8.83x | 12.7x | 11.1x | 10.2x | 9.25x |
| EV / EBITDA | 54.6x | 34.7x | 38.4x | 28.1x | 36.3x | 31.3x | 28.4x | 25.3x |
| EV / EBIT | 60.7x | 39x | 42.5x | 30.5x | 40.2x | 34.6x | 31.2x | 27.6x |
| EV / FCF | 89x | 88.9x | 60.3x | 42.6x | 51.7x | 44x | 40.3x | 35.7x |
| FCF Yield | 1.12% | 1.13% | 1.66% | 2.35% | 1.93% | 2.27% | 2.48% | 2.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 8.6 | 8.03 | 10.06 | 10.67 | 13.08 | 14.84 | 16.66 | 19 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3,215 | 3,367 | 3,661 | 3,898 | 4,304 | 4,757 | 5,168 | 5,648 |
| EBITDA 1 | 1,037 | 1,011 | 1,212 | 1,225 | 1,505 | 1,693 | 1,861 | 2,068 |
| EBIT 1 | 932 | 898.8 | 1,097 | 1,128 | 1,360 | 1,531 | 1,692 | 1,896 |
| Net income 1 | 744.8 | 679.1 | 845 | 887.9 | 1,059 | 1,200 | 1,318 | 1,476 |
| Net Debt 1 | 779.2 | 1,236 | 493.9 | 579.3 | 667.8 | 101.6 | -90.86 | -664 |
| Reference price 2 | 658.46 | 407.96 | 555.05 | 413.44 | 676.53 | 671.64 | 671.64 | 671.64 |
| Nbr of stocks (in thousands) | 84,794 | 82,817 | 83,052 | 81,885 | 79,851 | 78,781 | - | - |
| Announcement Date | 2/2/22 | 2/6/23 | 2/5/24 | 2/3/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 44.66x | 11.28x | 31.6x | -.--% | 52.91B | ||
| 36.44x | 4.29x | 16.1x | 2.35% | 191B | ||
| 21.35x | 3.66x | 13.1x | 2.86% | 122B | ||
| 26.33x | 4.72x | 16.13x | 1.18% | 117B | ||
| 32.8x | 3.15x | 12.71x | 2.17% | 96.21B | ||
| 17.92x | 0.21x | 13.38x | 0.7% | 64.47B | ||
| 29.83x | 7.43x | 18.98x | 1.36% | 52.51B | ||
| 40.48x | 3.63x | 12.36x | 2.1% | 54.1B | ||
| 43.69x | 3.46x | 12.85x | 0.5% | 35.65B | ||
| 33.29x | 5.98x | 18.73x | -.--% | 31.61B | ||
| Average | 32.68x | 4.78x | 16.59x | 1.32% | 81.64B | |
| Weighted average by Cap. | 31.43x | 4.44x | 15.95x | 1.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IDXX Stock
- Valuation IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















